Bristol Myers Squibb (CELG-RI) Tax Rate (2009 - 2026)
Bristol Myers Squibb (CELG-RI) reported Tax Rate of 17.31% for Q1 2026, up 18.0% year-over-year from 14.67% in Q1 2025, and down 33.72% quarter-over-quarter from 26.12% in Q4 2025.
Bristol Myers Squibb (CELG-RI) Tax Rate (2009 - 2026) Analysis & Trends
Bristol Myers Squibb (CELG-RI) has 18 years of Tax Rate data on file, last reported at 17.31% in Q1 2026.
- Tax Rate for Q1 2026 came in at 17.31%, up 18.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 24.22% (up 1323.0% YoY), and the FY2025 annual result was 24.36%, up 3097.0% from the prior year.
- Tax Rate declined to 17.31% in Q1 2026 per CELG-RI's latest filing, from 26.12% in the prior quarter.
- Over five years, Tax Rate peaked at 56.57% in Q4 2024 and troughed at 30.95% in Q2 2024.
- A 5-year average of 14.45% and a median of 18.16% in 2023 frame the typical range for Tax Rate.
- The sharpest annual moves came in 2023 and 2024: Tax Rate sank 3874 bps in 2023, then soared 6183 bps in 2024.
- A 5-year view of Tax Rate shows it stood at 8.93% in 2022, then jumped by 41 bps to 5.26% in 2023, then jumped by 1176 bps to 56.57% in 2024, then sank by 54 bps to 26.12% in 2025, then sank by 34 bps to 17.31% in 2026.
- Business Quant data shows CELG-RI's Tax Rate at 17.31% in Q1 2026, 26.12% in Q4 2025, and 29.51% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | -14.23% |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 16.43% |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 12.60% |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 32.92% |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | -20.26% |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 12.72% |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 21.67% |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 14.54% |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 17.31% |
| 10 | Bristol Myers Squibb | - | - | 8.07 Bn | 17.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.31% |
| Mar 31, 2026 | 17.31% |
| Dec 31, 2025 | 26.12% |
| Dec 31, 2025 | 26.12% |
| Sep 30, 2025 | 29.51% |
| Sep 30, 2025 | 29.51% |
| Jun 30, 2025 | 25.94% |
| Jun 30, 2025 | 25.94% |
| Mar 31, 2025 | 17.13% |
| Mar 31, 2025 | 17.13% |
| Dec 31, 2024 | 56.57% |
| Dec 31, 2024 | 56.57% |
| Sep 30, 2024 | 27.51% |
| Sep 30, 2024 | 27.51% |
| Jun 30, 2024 | -30.95% |
| Jun 30, 2024 | -30.95% |
| Mar 31, 2024 | -3.40% |
| Mar 31, 2024 | -3.40% |
| Dec 31, 2023 | -5.26% |
| Dec 31, 2023 | -5.26% |